Bilirubin lowering effect and safety of a prototype low cost blue light emitting diode (LED) phototherapy device in the treatment of indirect hyperbilirubinemia among healthy term infants in a tertiary government hospital

Ma. Lucila  M. Perez,; Vanessa Marie  V. Calabia,

Bilirubin lowering effect and safety of a prototype low cost blue light emitting diode (LED) phototherapy device in the treatment of indirect hyperbilirubinemia among healthy term infants in a tertiary government hospital

Vanessa Marie V. Calabia | Ma. Lucila M. Perez

Abstract:

Introduction: This was an exploratory study to evaluate if a prototype low-cost blue LED phototherapy device could lower total serum bilirubin (TSB) among term infants with indirect hyperbilirubinemia conducted as a preliminary requirement for a randomized trial. Safety of the prototype was likewise explored. Objective: This was an exploratory study to evaluate if a prototype low-cost blue LED phototherapy device could lower total serum bilirubin (TSB) among term infants with indirect hyperbilirubinemia conducted as a preliminary requirement for a randomized trial. Safety of the prototype was likewise explored. Methodology: After 24 hours, TSB decreased from baseline bilirubin levels by 16.5%. TSB levels after 24 hours were significantly lower than baseline levels (p = 0.0001). After 48 hours, the mean percentage of change of TSB was a 29% reduction. The proportion of subjects in the high-risk zone during baseline to 24th hour went down from 80% to 28% (p = 0.0003). No subjects had rebound hyperbilirubinemia after discontinuation of phototherapy. There were no complications. Results: The prototype low-cost blue LED phototherapy was able to lower serum bilirubin among term infants with indirect hyperbilirubinemia and appeared to be safe to use. Comparative studies with the standard phototherapy device are recommended. Conclusion: The prototype low-cost blue LED phototherapy was able to lower serum bilirubin among term infants with indirect hyperbilirubinemia and appeared to be safe to use. Comparative studies with the standard phototherapy device are recommended.

References:

Kumar P, Chawla D, Deorari A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database of Syst Rev 2011, 12. Art. No.: CD007969.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatr. 2004; 114:e297–316.
Managing Newborn Hyperbilirubinemia and Preventing Kernicterus. Progeny [Internet] Vol XX1X, No 1, June 2013 (cited 2017 November) 6p.Available from http://www.idph.state.ia.us/hpcdp/common/pdf/perinatal_newsletters/progeny_june2013.pdf
Chang YS, Hwang JH, Kwon HN, Choi CW, Ko SY, Park WS etal. In vitro and in vivo Efficacy of New Blue Light Emitting Diode Phototherapy Compared to Conventional Halogen Quartz Phototherapy for Neonatal Jaundice. J Korean Med Sci. 2005; 20: 61-4
Viau Colindres J, Rountree C, Destarac MA., Cul Y, Perez Valdez M, Herrera Castellanos M et al. Prospective Randomized Controlled Study Comparing Low-Cost LED and Conventional Phototherapy for Treatment of Neonatal Hyperbilirubinemia. J Trop Pediatr. 2012 Ju;58(3)178-83
Vreman HJ, et. al. A light emitting diode (LED) device for phototherapy of jaundice newborns: in vitro efficacy. Pediatr Res. 1997;41:185A.
Mohammadizadeh M, Eliadarani FK, Badiei Z. Is the light-emitting diode a better light source than fluorescent tube for phototherapy of neonatal jaundice in preterm infants?. Adv Biomed Res 2012;1:51.
Malkin R. and Anand V., A novel phototherapy device: the design community approach for the developing world. IEEE Eng Med Biol Mag. 2010 Mar-Apr;29(2):37-43.
Bhutani VK and The Committee on Fetus and Newborn. Phototherapy to prevent severe neonatal hyperbilirubinemiain the newborn infant 35 or more weeks of gestation. AAP. Pediatr.2011; 128:e1046–1052.
Rosen H, et. al., Use of a Light Emitting Diode(LED) Array for Bilirubin Phototransformation. Conf Proc IEEE Eng Med Biol Soc. 2005;7:7266-8.
Al-Masri HA. In healthy baby with severe jaundice do we need to give fluid supplementation during phototherapy? Sudan Med J. 2012 December;48(3):176-80.
Easa ZO. Effect of intravenous fluid supplementation on serum bilirubin level during conventional phototherapy of term infants with severe hyperbilirubinemia. QMJ. July 2010; 9:15
Yurdakök M. Phototherapy in the newborn: what’s new? JPNIM.2015;4(2):e040255
Marasigan KL, Perez ML. Prevalence and profile of neonates who developed hyperbilirubinemia admitted in a tertiary government hospital. Ospital ng Makati. November 2014. Unpublished.